The Greek cardiac magnetic resonance experience: A comparison with the EuroCMR registry

Hellenic Journal of Cardiology

Volumn 54, Issue 5, 2013, Pages 355-361

  Mavrogeni, Sophie ^a   Bratis, Konstantinos ^a   Papadopoulos, George ^b   Terrovitis, John ^c   Kitsiou, Anastasia ^d   Kattamis, Antonios ^b   Papavassiliou, Antigoni ^e   Ageli, Konstantina ^f   Kolovou, Genovefa ^a  

^a ONASSIS CARDIAC SURGERY CENTER   (Greece)

^b AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

^c LAIKO GENERAL HOSPITAL   (Greece)

^d SISMANOGLIO HOSPITAL   (Greece)

^e PENTELI CHILDREN S HOSPITAL   (Greece)

^f Hippokration University Hospital   (Greece)

Author keywords

Cardiac magnetic resonance; Coronary artery disease; Myocarditis; Thalassaemia

Indexed keywords

GADOLINIUM;

ADULT; ALLERGIC REACTION; ARTICLE; CARDIOMYOPATHY; CARDIOVASCULAR MAGNETIC RESONANCE; CATHETERIZATION; COMPUTER ASSISTED TOMOGRAPHY; CONGENITAL HEART DISEASE; COST BENEFIT ANALYSIS; DEVICE SAFETY; DYSPNEA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYOCARDITIS; PANIC; PATIENT CARE; REGISTER; RETROSPECTIVE STUDY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THALASSEMIA; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY;

ADULT; CARDIOVASCULAR DISEASES; EUROPE; FEMALE; GREECE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; REGISTRIES; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84885154357     PISSN: 11099666     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Fuster V, Kim RJ. Frontiers in cardiovascular magnetic resonance. Circulation. 2005; 112: 135-144.
2. Nagel E, Lehmkuhl HB, Bocksch W, et al. Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. Circulation. 1999; 99: 763-770.
3. Schwitter J, Nanz D, Kneifel S, et al. Assessment of myocardial perfusion in coronary artery disease by magnetic resonance: a comparison with positron emission tomography and coronary angiography. Circulation. 2001; 103: 2230-2235.
4. Schwitter J, Wacker CM, van Rossum AC, et al. MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial. Eur Heart J. 2008; 29: 480-489.
5. Jahnke C, Nagel E, Gebker R, et al. Prognostic value of cardiac magnetic resonance stress tests: adenosine stress perfusion and dobutamine stress wall motion imaging Circulation. 2007; 115: 1769-1776.
6. Giang TH, Nanz D, Coulden R, et al. Detection of coronary artery disease by magnetic resonance myocardial perfusion imaging with various contrast medium doses: first European multi-centre experience. Eur Heart J. 2004; 25: 1657-1665.
7. Mahrholdt H, Wagner A, Judd RM, Sechtem U, Kim RJ. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J. 2005; 26: 1461-1474.
8. Mavrogeni S. Evaluation of myocardial and hepatic iron loading by MRI T2* in multi-transfused patients with repeated blood loss as compared to thalassaemia major patients and controls. Blood Transfus. 2011; 9: 343-345.
9. Chouliaras GL, Kattamis A, Berdoukas V, Gotsis ED, Mavrogeni S, Ladis V. Cardiac magnetic resonance in transfusion dependent thalassaemia: assessment of iron load and relationship to left ventricular ejection fraction. Br J Haematol. 2010; 151: 397-401.
10. Mavrogeni S, Gotsis E, Verganelakis D, et al. Effect of iron overload on exercise capacity in thalassemic patients with heart failure. Int J Cardiovasc Imaging. 2009; 25: 777-783.
11. Mavrogeni S. Evaluation of myocardial iron overload using magnetic resonance imaging. Blood Transfus. 2009; 7: 183-187.
12. Mavrogeni S, Gotsis E, Ladis V, et al. Magnetic resonance evaluation of liver and myocardial iron deposition in thalassemia intermedia and b-thalassemia major. Int J Cardiovasc Imaging. 2008; 24: 849-854.
13. Mavrogeni S, Gotsis ED, Berdousi E, et al. Myocardial and hepatic T2* magnetic resonance evaluation in ex-thalassemic patients after bone-marrow transplantation. Int J Cardiovasc Imaging. 2007; 23: 739-745.
14. Mavrogeni SI, Markussis V, Kaklamanis L, et al. A comparison of magnetic resonance imaging and cardiac biopsy in the evaluation of heart iron overload in patients with beta-thalassemia major. Eur J Haematol. 2005; 75: 241-247.
15. Dimopoulou I, Kremastinos DT, Maris TG, Mavrogeni S, Tzelepis GE. Respiratory function in patients with thalassaemia and iron overload. Eur Respir J. 1999; 13: 602-605.
16. Mavrogeni SI, Gotsis ED, Markussis V, et al. T2 relaxation time study of iron overload in b-thalassemia. MAGMA. 1998; 6: 7-12.
17. Mavrogeni SI, Maris T, Gouliamos A, Vlahos L, Kremastinos DT. Myocardial iron deposition in beta-thalassemia studied by magnetic resonance imaging. Int J Card Imaging. 1998; 14: 117-122.
18. Bruder O, Schneider S, Nothnagel D, et al. EuroCMR (European Cardiovascular Magnetic Resonance) registry: results of the German pilot phase. J Am Coll Cardiol. 2009; 54: 1457-1466.
19. Mavrogeni S, Bratis K, van Wijk K, et al. Myocardial perfu sion-fibrosis pattern in systemic sclerosis assessed by cardiac magnetic resonance. Int J Cardiol. 2012; 159: e56-58.
20. Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J. 2008; 29: 2388-2442.
21. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000; 343: 1445-1453.
22. Friedrich MG, Sechtem U, Schulz-Menger J, et al. Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. J Am Coll Cardiol. 2009; 53: 1475-1487.
23. Klem I, Heitner JF, Shah DJ, et al. Improved detection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed enhancement infarction imaging. J Am Coll Cardiol. 2006; 47: 1630-1638.
24. Plein S, Schulz-Menger J, Almeida A, et al. Training and accreditation in cardiovascular magnetic resonance in Europe: a position statement of the working group on cardiovascular magnetic resonance of the European Society of Cardiology. Eur Heart J. 2011; 32: 793-798.
25. Mavrogeni S, Bratis K, Kolovou G. Myocardial ischemia and viability by cardiac magnetic resonance: the international experience and the Greek reality. Hellenic J Cardiol. 2012; 53: 55-62.
26. Baikoussis NG, Siminelakis SN, Kotsanti A, Achenbach K, Argyropoulou M, Goudevenos J. Multiple cerebral mycotic aneurysms due to left atrial myxoma: are there any pitfalls for the cardiac surgeon? Hellenic J Cardiol. 2011; 52: 466-468.
27. Nath MP, Dhawan N, Chauhan S, Kiran U. A large angiosarcoma of the right atrium: anaesthetic management. Hellenic J Cardiol. 2011; 52: 273-277.
28. Stougiannos PN, Danias PG, Karatzis EN, Kakkavas AT, Trikas AG. Incidental diagnosis of a large coronary fistula: angiographic and cardiac MRI findings. Hellenic J Cardiol. 2011; 52: 75-78.
29. Hendel RC, Patel MR, Kramer CM, et al. ACCF/ACR/SCCT/ SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American College of Radiology, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, American Society of Nuclear Cardiology, North American Society for Cardiac Imaging, Society for Cardiovascular Angiography and Interventions, and Society of Interventional Radiology. J Am Coll Cardiol. 2006; 48: 1475-1497.